Statistics
Publications
16
Citations
5.1K
H-Index
15
Active since
2000
Brenda K. Eustace is an author at Vertex Pharmaceuticals (United States) specializing in life sciences, cell biology, and medicine.
Publications per year
2000–2020
16
16
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Haydar Frangoul, David Altshuler, Maria Domenica Cappellini et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text
Life Sciences, Genetics, Hematology +17
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
Kevin E. Sloan, Brenda K. Eustace, Jean K. Stewart et al. · BMC Cancer · 2004 · 243 citations · Full text
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
Amy B. Hall, Dave Newsome, Yuxin Wang et al. · Oncotarget · 2014 · 195 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 16